AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33891508 — intervention group
Group type: EXPERIMENTAL
Intervention: Nintendo Ring Fit Adventure (RFA) exergame, performed once a week for 40 minutes for 8 weeks
Number of subjects: 20
Study 33891508 — intervention group
Group type: COMPARATOR
Intervention: Oral treatment for 8 weeks
Number of subjects: 20
Study 35164484 — intervention group
Group type: EXPERIMENTAL
Intervention: Miller size 0 blade
Number of subjects: 40
Study 35164484 — intervention group
Group type: COMPARATOR
Intervention: Macintosh size 0 blade
Number of subjects: 40
Study 35536547 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous dendritic cell vaccine (DCVAC)
Number of subjects: 82
Study 35536547 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care chemotherapy
Number of subjects: 82
Study 33215434 — intervention group
Group type: EXPERIMENTAL
Intervention: Central European diet (CED)
Number of subjects: 144
Study 33215434 — intervention group
Group type: COMPARATOR
Intervention: Mediterranean diet (MED)
Number of subjects: 144
Study 32672505 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive safety decision aid (myPlan)
Number of subjects: 354
Study 32672505 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthcare provider for contraception
Number of subjects: 354
Study 32201619 — intervention group
Group type: EXPERIMENTAL
Intervention: Early BCG vaccination
Number of subjects: 6500
Study 32201619 — intervention group
Group type: EXPERIMENTAL
Intervention: Early BCG vaccination (administered in November to January)
Number of subjects: 6500
Study 32201619 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG vaccination
Number of subjects: 6500
Study 36219750 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser 1‐1 J/point (L1J)
Number of subjects: 158
Study 36219750 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser 2‐2 J/point (L2J)
Number of subjects: 158
Study 36219750 — intervention group
Group type: COMPARATOR
Intervention: Placebo‐0 J/point
Number of subjects: 158
Study 36219750 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser 1‐1 J/point (L1J) and Laser 2‐2 J/point (L2J)
Number of subjects: 158
Study 33483965 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent serial casting in conjunction with occupational therapy and botulinum neurotoxin A (BoNT‐A)
Number of subjects: 34
Study 33483965 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving BoNT‐A and occupational therapy without casting
Number of subjects: 34
Study 32432556 — intervention group
Group type: EXPERIMENTAL
Intervention: SMS text messaging and consultations for 3 months
Number of subjects: 384
Study 32432556 — intervention group
Group type: COMPARATOR
Intervention: Usual care for 3 months
Number of subjects: 384
Study 36151698 — intervention group
Group type: EXPERIMENTAL
Intervention: Live-in caregivers
Number of subjects: 47
Study 36151698 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregivers with fair or poor sleep quality
Number of subjects: 47
Study 36151698 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregivers with decreased sleep quality
Number of subjects: 47
Study 34561890 — intervention group
Group type: EXPERIMENTAL
Intervention: High-sensitivity cardiac troponin T (hs-cTnT) > 14 ng/l
Number of subjects: 889
Study 34561890 — intervention group
Group type: EXPERIMENTAL
Intervention: High-sensitivity cardiac troponin T (hs-cTnT) ≤ 14 ng/l
Number of subjects: 889
Study 34561890 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower risk category (ABCD2 score 0-5) with hs-cTnT > URL
Number of subjects: 889
Study 34561890 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower risk category (ABCD2 score 0-5) with hs-cTnT ≤ URL
Number of subjects: 889
Study 34561890 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher risk category (ABCD2 score 6-7)
Number of subjects: 889
Study 32556865 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial Neural Networks (ANNs) model for predicting 1-year progression-free survival (PFS)
Number of subjects: 2890
Study 32556865 — intervention group
Group type: EXPERIMENTAL
Intervention: ANNs model for estimating 1-year overall survival (OS)
Number of subjects: 2890
Study 32556865 — intervention group
Group type: COMPARATOR
Intervention: High-risk group based on ANNs model scores
Number of subjects: 2890
Study 35642490 — intervention group
Group type: EXPERIMENTAL
Intervention: Mat Pilates training (3 times a week for 12 weeks)
Number of subjects: 47
Study 33436709 — intervention group
Group type: EXPERIMENTAL
Intervention: High-salt diet
Number of subjects: 18
Study 33436709 — intervention group
Group type: COMPARATOR
Intervention: Low-salt diet
Number of subjects: 18
Study 32236533 — intervention group
Group type: EXPERIMENTAL
Intervention: Indirect response comparing the patient's condition with that of other patients
Number of subjects: 302
Study 32236533 — intervention group
Group type: EXPERIMENTAL
Intervention: Indirect response describing the patient's deteriorating physiological condition
Number of subjects: 302
Study 32236533 — intervention group
Group type: EXPERIMENTAL
Intervention: Redirection to a discussion of the patient's values and goals
Number of subjects: 302
Study 32236533 — intervention group
Group type: COMPARATOR
Intervention: Direct response (control)
Number of subjects: 302
Study 34546341 — intervention group
Group type: EXPERIMENTAL
Intervention: ENHANCE LTC review (intervention period)
Number of subjects: 466
Study 34546341 — intervention group
Group type: COMPARATOR
Intervention: Usual LTC reviews (control period)
Number of subjects: 466
Study 33084829 — intervention group
Group type: EXPERIMENTAL
Intervention: Problematization educational intervention
Number of subjects: 202
Study 33084829 — intervention group
Group type: COMPARATOR
Intervention: Conventional monitoring
Number of subjects: 202
Study 34914128 — intervention group
Group type: EXPERIMENTAL
Intervention: Tripartite intervention (behavioral state modulation + nonnutritive sucking + tucking)
Number of subjects: 64
Study 34914128 — intervention group
Group type: EXPERIMENTAL
Intervention: Tripartite intervention
Number of subjects: 64
Study 34914128 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control condition)
Number of subjects: 64
Study 33098889 — intervention group
Group type: EXPERIMENTAL
Intervention: TotalFill BC sealer
Number of subjects: 160
Study 33098889 — intervention group
Group type: COMPARATOR
Intervention: AH Plus sealer
Number of subjects: 160
Study 33302878 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative volume replacement therapy (VRT)
Number of subjects: 7
Study 33302878 — intervention group
Group type: COMPARATOR
Intervention: Usual care (no VRT)
Number of subjects: 7
Study 33795096 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated assessment (contextualizing scenario)
Number of subjects: 30
Study 33795096 — intervention group
Group type: COMPARATOR
Intervention: Non-integrated assessment (no integration)
Number of subjects: 30
Study 33795096 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated assessment
Number of subjects: 30
Study 35713012 — intervention group
Group type: EXPERIMENTAL
Intervention: Grapeseed oil-loaded dermocosmetic nanoemulgel
Number of subjects: 15
Study 35713012 — intervention group
Group type: COMPARATOR
Intervention: Placebo formulation
Number of subjects: 15
Study 34166970 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive PCA treatment (3 hours/day, 4 days/week for 2.5 weeks)
Number of subjects: 16
Study 34166970 — intervention group
Group type: COMPARATOR
Intervention: Standard PCA treatment (1 hour/day, 3 days/week for 10 weeks)
Number of subjects: 16
Study 34166970 — intervention group
Group type: EXPERIMENTAL
Intervention: Both IT and ST conditions
Number of subjects: 16
Study 34166970 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-generation of phonological components
Number of subjects: 16
Study 32228029 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry needling (DN)
Number of subjects: 30
Study 32228029 — intervention group
Group type: COMPARATOR
Intervention: Pressure release
Number of subjects: 30
Study 36215318 — intervention group
Group type: EXPERIMENTAL
Intervention: Patterned 2D ferroelectric perovskite (PMA)2PbCl4 microbelt arrays; flexible photodetectors under 320 nm illumination.
Number of subjects: 0
Study 36215318 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible PD with piezo-phototronic effect under external tensile strain of 0.71%.
Number of subjects: 0
Study 33785069 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil (3 to 4 μg/kg)
Number of subjects: 1150
Study 33785069 — intervention group
Group type: COMPARATOR
Intervention: Rapid-onset paralytic agents (succinylcholine or rocuronium 1 mg/kg)
Number of subjects: 1150
Study 32390164 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiamidol applied four times daily
Number of subjects: 117
Study 32390164 — intervention group
Group type: COMPARATOR
Intervention: Thiamidol applied two times daily
Number of subjects: 117
Study 32390164 — intervention group
Group type: EXPERIMENTAL
Intervention: Typical face care regimen containing Thiamidol (day care SPF 30 in the morning, serum and night care in the evening)
Number of subjects: 117
Study 34850647 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilastine 10 mg/day
Number of subjects: 0
Study 34850647 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33357604 — intervention group
Group type: EXPERIMENTAL
Intervention: Distress Tolerance Intervention (DTI)
Number of subjects: 60
Study 33357604 — intervention group
Group type: COMPARATOR
Intervention: Healthy Video Control (HVC)
Number of subjects: 60
Study 32956479 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclopentolate 1% as spray
Number of subjects: 61
Study 32956479 — intervention group
Group type: COMPARATOR
Intervention: Cyclopentolate 1% as drops
Number of subjects: 61
Study 34871469 — intervention group
Group type: EXPERIMENTAL
Intervention: Personality Disorder Cluster A
Number of subjects: 94
Study 34871469 — intervention group
Group type: EXPERIMENTAL
Intervention: Personality Disorder Cluster B
Number of subjects: 94
Study 34871469 — intervention group
Group type: EXPERIMENTAL
Intervention: Personality Disorder Cluster C
Number of subjects: 94
Study 32737814 — intervention group
Group type: EXPERIMENTAL
Intervention: Impression Management (IM) scores among males
Number of subjects: 321
Study 32737814 — intervention group
Group type: EXPERIMENTAL
Intervention: NORC DSM-IV screen for gambling problems (NODS)
Number of subjects: 321
Study 32737814 — intervention group
Group type: EXPERIMENTAL
Intervention: Gambling Symptom Assessment Scale (G-SAS) scores
Number of subjects: 321
Study 32861496 — intervention group
Group type: EXPERIMENTAL
Intervention: Enrofloxacin (ENR)
Number of subjects: 0
Study 32861496 — intervention group
Group type: EXPERIMENTAL
Intervention: Tulathromycin (TUL)
Number of subjects: 0
Study 32861496 — intervention group
Group type: COMPARATOR
Intervention: Control (CTL)
Number of subjects: 0
Study 34608048 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised 8- to 12-week physical exercise program
Number of subjects: 20
Study 34608048 — intervention group
Group type: COMPARATOR
Intervention: Usual physical activity
Number of subjects: 20
Study 35915198 — intervention group
Group type: EXPERIMENTAL
Intervention: Abemaciclib 200 mg monotherapy twice daily with a meal
Number of subjects: 72
Study 35915198 — intervention group
Group type: EXPERIMENTAL
Intervention: Abemaciclib 200 mg monotherapy twice daily in a modified fasting state
Number of subjects: 72
Study 35915198 — intervention group
Group type: EXPERIMENTAL
Intervention: Abemaciclib 200 mg monotherapy twice daily without regard to food
Number of subjects: 72
Study 35915198 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 72
Study 33331923 — intervention group
Group type: EXPERIMENTAL
Intervention: WBRT + erlotinib
Number of subjects: 224
Study 33331923 — intervention group
Group type: COMPARATOR
Intervention: WBRT
Number of subjects: 224
Study 33331923 — intervention group
Group type: EXPERIMENTAL
Intervention: WBRT + erlotinib (EGFR-mutant)
Number of subjects: 224
Study 33331923 — intervention group
Group type: COMPARATOR
Intervention: WBRT (EGFR-mutant)
Number of subjects: 224
Study 33331923 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 224
Study 36414282 — intervention group
Group type: EXPERIMENTAL
Intervention: Balanced opioid-free anaesthesia (esketamine, dexmedetomidine, sevoflurane)
Number of subjects: 120
Study 36414282 — intervention group
Group type: COMPARATOR
Intervention: Sufentanil and sevoflurane (control group)
Number of subjects: 120
Study 36414282 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (OFA and control)
Number of subjects: 120
Study 34049857 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab plus prednisone (TCZ/PDN)
Number of subjects: 250
Study 34049857 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus prednisone (PBO/PDN)
Number of subjects: 250
Study 32835560 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E blended highly cross-linked polyethylene (HXLPE) acetabular cup
Number of subjects: 199
Study 32835560 — intervention group
Group type: COMPARATOR
Intervention: Uncemented UHMWPE monoblock cup
Number of subjects: 199
Study 36544322 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal transcranial direct current stimulation (a‐tDCS)
Number of subjects: 80
Study 36544322 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive training
Number of subjects: 80
Study 36544322 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS plus cognitive training
Number of subjects: 80
Study 36544322 — intervention group
Group type: COMPARATOR
Intervention: Sham
Number of subjects: 80
Study 34696998 — intervention group
Group type: EXPERIMENTAL
Intervention: Micro-osteoperforation (MOP)
Number of subjects: 25
Study 34696998 — intervention group
Group type: COMPARATOR
Intervention: Control (no MOP)
Number of subjects: 25
Study 34533383 — intervention group
Group type: EXPERIMENTAL
Intervention: Social media engagement in longitudinal research
Number of subjects: 0
Study 34533383 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-based adolescent substance use intervention
Number of subjects: 0
Study 34368848 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol 2008-2015
Number of subjects: 1231
Study 34368848 — intervention group
Group type: COMPARATOR
Intervention: Protocol 2000-2007
Number of subjects: 1231
Study 34368848 — intervention group
Group type: EXPERIMENTAL
Intervention: Both protocols
Number of subjects: 1231
Study 34880615 — intervention group
Group type: EXPERIMENTAL
Intervention: Esketamine nasal spray plus newly initiated antidepressant
Number of subjects: 565
Study 34880615 — intervention group
Group type: COMPARATOR
Intervention: Antidepressant plus placebo
Number of subjects: 565
Study 34880615 — intervention group
Group type: EXPERIMENTAL
Intervention: Esketamine nasal spray
Number of subjects: 565
Study 34880615 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatment groups
Number of subjects: 565
Study 32888115 — intervention group
Group type: EXPERIMENTAL
Intervention: Ion-releasing coating material
Number of subjects: 28
Study 32888115 — intervention group
Group type: COMPARATOR
Intervention: Control material (non-active group)
Number of subjects: 28
Study 32021143 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycopyrrolate/formoterol fumarate metered dose inhaler (GFF MDI) 18/9.6 µg
Number of subjects: 466
Study 32021143 — intervention group
Group type: COMPARATOR
Intervention: Placebo MDI
Number of subjects: 466
Study 35060417 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (6 mg)
Number of subjects: 8
Study 35060417 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 33325785 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvanted Escherichia coli adhesin vaccine
Number of subjects: 67
Study 33063220 — intervention group
Group type: EXPERIMENTAL
Intervention: Indirect pulp treatment (IPT)
Number of subjects: 67
Study 33063220 — intervention group
Group type: COMPARATOR
Intervention: iRoot BP Plus pulpotomy
Number of subjects: 67
Study 35643392 — intervention group
Group type: EXPERIMENTAL
Intervention: Nociception Level (NOL) index
Number of subjects: 0
Study 35643392 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean Arterial Pressure (MAP)
Number of subjects: 0
Study 35643392 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart Rate (HR)
Number of subjects: 0
Study 33507550 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 g glucose drink
Number of subjects: 0
Study 33507550 — intervention group
Group type: COMPARATOR
Intervention: Equivalent volume of water (control)
Number of subjects: 0
Study 32020725 — intervention group
Group type: EXPERIMENTAL
Intervention: Adolescent report of quality of life (PedsQL score 79.1)
Number of subjects: 102
Study 32020725 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental report of quality of life (PedsQL score 80.2)
Number of subjects: 102
Study 32020725 — intervention group
Group type: COMPARATOR
Intervention: Parental report
Number of subjects: 102
Study 32020725 — intervention group
Group type: COMPARATOR
Intervention: Parental report on 'pain and hurt' domain
Number of subjects: 102
Study 32020725 — intervention group
Group type: COMPARATOR
Intervention: Parental report on 'social communication' domain
Number of subjects: 102
Study 32020725 — intervention group
Group type: COMPARATOR
Intervention: Parental report of total PedsQL scores in male adolescents
Number of subjects: 102
Study 32020725 — intervention group
Group type: COMPARATOR
Intervention: Parental report of total PedsQL scores in female adolescents
Number of subjects: 102
Study 33591484 — intervention group
Group type: EXPERIMENTAL
Intervention: FamilyTalk educational tool
Number of subjects: 208
Study 33591484 — intervention group
Group type: EXPERIMENTAL
Intervention: Pathogenic or likely pathogenic (P/LP) results
Number of subjects: 208
Study 33591484 — intervention group
Group type: EXPERIMENTAL
Intervention: Variant of uncertain significance (VUS) results
Number of subjects: 208
Study 32449228 — intervention group
Group type: EXPERIMENTAL
Intervention: Mommy go protocol
Number of subjects: 0
Study 32449228 — intervention group
Group type: COMPARATOR
Intervention: Traditional support (Control)
Number of subjects: 0
Study 36085211 — intervention group
Group type: EXPERIMENTAL
Intervention: Active DCP
Number of subjects: 761
Study 36085211 — intervention group
Group type: COMPARATOR
Intervention: Passive DCP
Number of subjects: 761
Study 33351120 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 114
Study 33351120 — intervention group
Group type: COMPARATOR
Intervention: Standard anticoagulants
Number of subjects: 114
Study 34563429 — intervention group
Group type: EXPERIMENTAL
Intervention: Benefit-Finding Therapeutic (BFT) intervention
Number of subjects: 129
Study 34563429 — intervention group
Group type: COMPARATOR
Intervention: Simplified psychoeducation
Number of subjects: 129
Study 34563429 — intervention group
Group type: COMPARATOR
Intervention: Standard psychoeducation
Number of subjects: 129
Study 34664858 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurofeedback combined with acupuncture treatment
Number of subjects: 44
Study 34664858 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture treatment
Number of subjects: 44
Study 35929983 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 60
Study 34514678 — intervention group
Group type: EXPERIMENTAL
Intervention: PEG‐IFN‐? monotherapy
Number of subjects: 651
Study 34514678 — intervention group
Group type: EXPERIMENTAL
Intervention: PEG‐IFN‐? plus NA de novo combination
Number of subjects: 651
Study 34514678 — intervention group
Group type: COMPARATOR
Intervention: PEG‐IFN‐? add‐on to NA
Number of subjects: 651
Study 34514678 — intervention group
Group type: COMPARATOR
Intervention: NA monotherapy
Number of subjects: 651
Study 34514678 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall flares
Number of subjects: 651
Study 35671649 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose methotrexate (LD-MTX)
Number of subjects: 1429
Study 32825996 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry needling (DN)
Number of subjects: 30
Study 32825996 — intervention group
Group type: COMPARATOR
Intervention: Sham dry needling (Control)
Number of subjects: 30
Study 34268633 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Standardized Patients (VSPs) training
Number of subjects: 0
Study 34268633 — intervention group
Group type: EXPERIMENTAL
Intervention: VSP training
Number of subjects: 0
Study 32432553 — intervention group
Group type: EXPERIMENTAL
Intervention: Tablet intervention consisting of information about IPV and safety behaviors during prenatal care.
Number of subjects: 9
Study 32432553 — intervention group
Group type: EXPERIMENTAL
Intervention: Tablet intervention (video to promote safety behaviors delivered on a tablet).
Number of subjects: 9
Study 32432553 — intervention group
Group type: EXPERIMENTAL
Intervention: Tablet intervention.
Number of subjects: 9
Study 35031147 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradermal administration using Immucise™
Number of subjects: 0
Study 35031147 — intervention group
Group type: COMPARATOR
Intervention: Standard subcutaneous (SC) administration of seasonal influenza vaccine
Number of subjects: 0
Study 34690144 — intervention group
Group type: COMPARATOR
Intervention: Memantine 20 mg
Number of subjects: 8
Study 34690144 — intervention group
Group type: EXPERIMENTAL
Intervention: Memantine 10 mg bid (24-week unblinded active-dose therapeutic trial)
Number of subjects: 8
Study 34690144 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 35560363 — intervention group
Group type: EXPERIMENTAL
Intervention: mnemoPQQ® (21.5 mg/day)
Number of subjects: 64
Study 35560363 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 33231105 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination doses of ketamine and dexmedetomidine, given intranasally
Number of subjects: 410
Study 33231105 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal combination therapy
Number of subjects: 410
Study 33231105 — intervention group
Group type: EXPERIMENTAL
Intervention: Proposed trial design
Number of subjects: 410
Study 33231105 — intervention group
Group type: EXPERIMENTAL
Intervention: Bayesian predictive power of the trial
Number of subjects: 410
Study 33231105 — intervention group
Group type: COMPARATOR
Intervention: Comparative effectiveness analysis
Number of subjects: 410
Study 32569125 — intervention group
Group type: EXPERIMENTAL
Intervention: NBAC
Number of subjects: 30
Study 32569125 — intervention group
Group type: EXPERIMENTAL
Intervention: BAC
Number of subjects: 30
Study 32569125 — intervention group
Group type: EXPERIMENTAL
Intervention: All supplements
Number of subjects: 30
Study 32569125 — intervention group
Group type: COMPARATOR
Intervention: PLA
Number of subjects: 30